<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02023840</url>
  </required_header>
  <id_info>
    <org_study_id>07.2013.ERYTHRITOL.PROED</org_study_id>
    <nct_id>NCT02023840</nct_id>
  </id_info>
  <brief_title>The Use of Erythritol Powder and Metronidazole Gel for the Non-surgical Treatment of Periodontitis</brief_title>
  <official_title>The Use of Erythritol Powder and Locally Derived Metronidazole for the Non-surgical Treatment of Periodontitis: a Split-mouth Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Proed, Torino, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Proed, Torino, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the present study is evaluate the use of erythritol powder with/without the adjunct of&#xD;
      local metronidazole in the treatment of periodontal pockets.&#xD;
&#xD;
      20 consecutive adult periodontal patients, requiring cause-related therapy as phase 1 of&#xD;
      their treatment plan, and presenting ≥4 sites with probing pocket depth ≥4mm will be&#xD;
      enrolled. For each patients four sites will be considered for the study, and two sites will&#xD;
      be allocated in the test group and two sites will be allocated in the control group. In the&#xD;
      test group, ultrasonic debridement of the pocket will be performed using a piezoceramic&#xD;
      ultrasonic device with the a tip connected to the handpiece for 5 minutes/pocket. Then, it&#xD;
      will be followed by the subgingival use of erythritol powder 2x5 seconds/pocket. At this time&#xD;
      the subgingival delivery of metronidazole gel will be provided. In the control group, the&#xD;
      same protocol will be used except for the use of a placebo instead of metronidazole. After&#xD;
      instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2 weeks.&#xD;
&#xD;
      At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated:&#xD;
      Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The long term results and benefit of infection control in the treatment of periodontal&#xD;
      disease have been well documented. According to a cause-related concept, the disruption of&#xD;
      bacterial plaque biofilms can be defined as primary objective for the treatment of&#xD;
      periodontitis.&#xD;
&#xD;
      In the past few years, glycine powder air polishing showed positive outcomes in removing&#xD;
      subgingival biofilm in periodontal pockets, and subgingivally delivered metronidazole seemed&#xD;
      to improve the results of scaling and root-planing alone . Recently, a new prophylactic&#xD;
      powder has been developed. The special action of the powder is attributable to the new&#xD;
      ingredient Erythritol and the extra-fine grains that measure only 14 microns. The small size&#xD;
      results on one hand in a minimal impact per grain on the treated surface and on the other&#xD;
      hand in a very dense jet of powder, efficient on biofilm.&#xD;
&#xD;
      Aim of the present study is evaluate the use of erythritol powder with/without the adjunct of&#xD;
      local metronidazole in the treatment of periodontal pockets.&#xD;
&#xD;
      MATERIALS &amp; METHODS:&#xD;
&#xD;
      20 consecutive adult periodontal patients, requiring cause-related therapy as phase 1 of&#xD;
      their treatment plan, and presenting ≥4 sites with probing pocket depth ≥4mm will be&#xD;
      enrolled. For each patients four sites will be considered for the study, and two sites will&#xD;
      be allocated in the test group and two sites will be allocated in the control group. In the&#xD;
      test group, ultrasonic debridement of the pocket will be performed using a piezoceramic&#xD;
      ultrasonic device with the tip connected to the Handpiece Led for 5 minutes/pocket. Then, it&#xD;
      will be followed by the subgingival use of erythritol powder applied by the use of Perio-Flow&#xD;
      Handpiece with Perio-Flow Nozzle, connected to an airflow unit 2x5 seconds/pocket. At this&#xD;
      time the subgingival delivery of metronidazole gel will be provided. In the control group,&#xD;
      the same protocol will be used except for the use of a placebo instead of metronidazole.&#xD;
      After instrumentation, patients will rinse with chlorhexidine 0.20% 3 times/day for 2 weeks.&#xD;
&#xD;
      At baseline, 1 month, 3 months and 6 months the following parameters will be evaluated:&#xD;
      Probing Pocket depth (PPD), Bleeding on Probing (BoP), Clinical Attachment Level (CAL).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Probing pocket Depth change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Using a periodontal calibrated PCP-15 mm probe, the pocket depth will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding on Probing change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Using a periodontal calibrated PCP-15 mm probe, the bleeding on probing will be detected</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Attachment level change</measure>
    <time_frame>baseline, 6 months</time_frame>
    <description>Using a periodontal calibrated PCP-15 mm probe, the attachment level will be measured</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Periodontal Pocket</condition>
  <arm_group>
    <arm_group_label>ultrasonics and erythritol, metronidazole gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and root planing with ultrasonics and erythritol air powder will be followed by application of metronidazole gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ultrasonics and erythritol, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Scaling and root planing with ultrasonics and erythritol air powder will be followed by application of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metronidazole gel</intervention_name>
    <arm_group_label>ultrasonics and erythritol, metronidazole gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasonics</intervention_name>
    <arm_group_label>ultrasonics and erythritol, metronidazole gel</arm_group_label>
    <arm_group_label>ultrasonics and erythritol, placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>erythritol</intervention_name>
    <arm_group_label>ultrasonics and erythritol, metronidazole gel</arm_group_label>
    <arm_group_label>ultrasonics and erythritol, placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>ultrasonics and erythritol, placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients suffering from periodontitis at least 4 sites with probing pocket depth&#xD;
             =&gt;4mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Heavy smokers current pregnant patients history of malignancy Long term steroidal or&#xD;
             antibiotic therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniele Cardaropoli, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Proed, Torino, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PROED, Institute for Professional Education in Dentistry</name>
      <address>
        <city>Torino</city>
        <zip>10129</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>December 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2013</study_first_posted>
  <last_update_submitted>September 1, 2016</last_update_submitted>
  <last_update_submitted_qc>September 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>pockets</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periodontal Pocket</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Erythritol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

